Jeremy D Gale Selected Research

Diabetic Nephropathies (Diabetic Nephropathy)

11/2018

Effect of PF-04634817, an Oral CCR2/5 Chemokine Receptor Antagonist, on Albuminuria in Adults with Overt Diabetic Nephropathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeremy D Gale Research Topics

Disease

2	Ulcerative Colitis 12/2023 - 01/2023
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 03/2021
2	Fibrosis (Cirrhosis) 01/2021 - 09/2018
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020 - 11/2004
2	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2011 - 09/2010
2	Hypersensitivity (Allergy) 01/2011 - 09/2010
1	Reperfusion Injury 01/2022
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Brain Diseases (Brain Disorder) 01/2021
1	Ascites 01/2021
1	Hemorrhage 01/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021
1	Chronic Hepatitis C 01/2021
1	Obstructive Jaundice (Cholestatic Jaundice) 01/2021
1	End Stage Liver Disease 01/2021
1	Crohn Disease (Crohn's Disease) 01/2020
1	Disease Progression 01/2020
1	Type 2 Diabetes Mellitus (MODY) 11/2018
1	Albuminuria 11/2018
1	Diabetic Nephropathies (Diabetic Nephropathy) 11/2018
1	Hypertrophic Cicatrix (Hypertrophic Scar) 09/2018
1	Cicatrix (Scar) 09/2018
1	Surgical Wound 09/2018
1	Macular Edema 01/2018
1	Constipation 05/2009
1	Colitis 11/2004

Drug/Important Bio-Agent (IBA)

3	LigandsIBA 01/2018 - 09/2010
2	Phosphotransferases (Kinase)IBA 12/2023 - 01/2023
2	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2020
2	TYK2 Kinase (Tyrosine Kinase 2)IBA 01/2022 - 03/2021
2	ropsacitinibIBA 01/2022 - 03/2021
2	PF-04634817IBA 11/2018 - 01/2018
2	CC ChemokinesIBA 11/2018 - 01/2018
2	Pregabalin (Lyrica)FDA Link 01/2011 - 09/2010
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	Adenosine (Adenocard)FDA LinkGeneric 01/2022
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2022
1	Alkaline PhosphataseIBA 01/2022
1	CollagenIBA 01/2021
1	ChemokinesIBA 11/2018
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2018
1	Chemokine ReceptorsIBA 11/2018
1	Angiotensin Receptor AntagonistsIBA 11/2018
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 11/2018
1	Antisense OligonucleotidesIBA 09/2018
1	Connective Tissue Growth FactorIBA 09/2018
1	Proteins (Proteins, Gene)FDA Link 09/2018
1	Ranibizumab (Lucentis)FDA Link 01/2018
1	Gabapentin (Neurontin)FDA LinkGeneric 01/2011
1	Calcium Channels (Calcium Channel)IBA 09/2010
1	Lubiprostone FDA Link 05/2009
1	tegaserod (Zelnorm)FDA Link 05/2009
1	ChloridesIBA 05/2009
1	Chloride Channels (Chloride Channel)IBA 05/2009
1	Dexamethasone (Maxidex)FDA LinkGeneric 11/2004
1	CytokinesIBA 11/2004
1	Interleukin-8 (Interleukin 8)IBA 11/2004

Therapy/Procedure

4	Therapeutics 12/2023 - 11/2018
1	Liver Transplantation 01/2021
1	Intradermal Injections 09/2018